Tagged with Healthcare

Switzerland Frederic Bengold, MD of Servier Switzerland, on the affiliate’s main growth drivers, an exciting collaboration with Novartis on heart failure medication, and the intricacies of market access in Switzerland. Could you please start by introducing Servier’s Swiss affiliate? We enjoy a longstanding presence and reputation in Switzerland. The local affiliate…

Philippines Javish Abichandani, Chief Executive Officer of AGlobal Care Inc. in the Philippines, outlines the company’s extensive product portfolio as well as their ambitions to bring more high-quality, affordable medications into the Philippines. He also discusses how the company is evolving to meet the demands of the dynamic pharmaceutical industry in…

Singapore The Asia-Pacific region is a vast geographic area, home to almost half of the world’s population and numerous emerging and developed markets with great investment potential for healthcare and life sciences companies. However, the degree of diversity within Asia-Pacific creates formidable challenges for MNCs operating in the region. “APAC is…

Taiwan Thomas Yuan, the CEO of TFBS Bioscience, documents the tailored added-value that this fast-growing product testing company strives to bring to emerging pharmaceutical and biotech companies in the Asia Pacific region, while TFBS already stands out as the only service provider of its kind in Taiwan and one of the…

Ireland Ger Brennan, MD (Human Health) of MSD Ireland, highlights his mandate to position MSD for success in an evolving healthcare landscape, the groundbreaking new report on Irish healthcare attitudes and perspectives MSD commissioned, the opportunities and challenges within the Irish market, and MSD’s commitment to putting patients at the center…

Singapore Singapore has pioneered multiple aspects of QuintilesIMS’s global business, and the high profile merger has created interesting opportunities for the organization within the APAC region, beyond strong synergies at the global level. It’s a pleasure to meet with you Anand, as this is the first time PharmaBoardroom has met with…

Philippines Jose Augusto Pascual, President and CEO of PascualLab, sheds light on the company’s current footprint in the Philippines, as well as their ambitions to even further expand their manufacturing capabilities. He also discusses PascualLab’s efforts to be the partner of choice for companies looking to expand into the Philippines. To…

Ireland Ronan Quinn, CEO of Ardmac, an international provider of high-tech cleanroom facilities to the life sciences sector, tells us the inspiring story of Ardmac’s continued growth through the recent economic recession, the second-generation cleanroom technologies they are bringing to the market, and his positive outlook for Ardmac in the next…

Luxembourg Despite its miniscule size, Luxembourg has managed to specialize in three key areas and now has a strong claim to be a global leader in personalized healthcare, e-health and data security, and pharma logistics and air freight. “In championing personalized health, the Luxembourg authorities are indicating that they are both…

Philippines Meneleo Hernandez, Jr., President of Multicare, describes Lupin Pharma’s Multicare operations in the Philippines and how their niche business unit strategy and strategic partnerships create a sustainable business model that is driving growth for the branded generics company. As the President of Multicare, could you provide an introduction to Lupin…

Philippines Ivan Alexi Arota, country manager of GE Healthcare Philippines, discusses the company’s extensive efforts to increase access to their innovative, affordable products throughout the country.  He also expands on the important role that partnerships, both with the government and other private companies, play in terms of growing the company as…

Philippines Bakhuti Shengelia, Director Healthcare Systems of Novartis International AG, expands on Novartis’ initiatives to increase access to healthcare in emerging markets as well as the importance of transitioning towards value-based healthcare systems to improve healthcare outcomes. He also discusses how emerging markets are able leverage the fact they have more…